When pondering
why doctors who means well can get it so wrong, simply look to pharma. Since
2004 when I started healthfully.org I
have been examining health issues and discovered the corruption worked by
pharma. A major shift began in the Reagan
era: medical colleges became ever
increasingly dependent upon pharma for funding and as a consequence are
pharma-friendly KLOs (Key Opinion Leaders) have
replaced the previous generation of independent KOLs. KOLs run clinical trials, author most journal articles, sit
on
committees that write clinical guidelines, write medical textbooks, most are
university professors, and they give the required continuing education classes
of doctors, which are pharma funded. For
services the KOLs receive 6-figure
yearly income. Thus there is a seamless content connection between clinical
trials, textbooks, school classes, clinical guidelines, and continuing
education classes. Starting in medical
school the future doctors are taught that for every condition there is safe and effective
pills—the mantra of
pharma. Every noted expert in a field
of medicine is a pharma-friendly
KOL. Pharma through KOLs has
framed the medical subjects to
promote their profits. Pharma has
replaced the scientific foundation of medicine with tobacco science—the spin
too often is dazzling heights. It is all
about profits and pharma is very good at marketing.
With broad strokes
I shall describe the
method used to create our broken medical system. Forty years ago pharma gave
university
professors funds to run clinical trials and permitted them to write unhindered
the journal articles. That has changed,
for the last 3 decades pharma has been running directly or indirectly all the
large clinical trials;[1] and they own the
results. Pharma designs all
its clinical trials for market
objectives; it is tobacco science. (The
few trials funded by the FDA support pharma’s goals.) The phase-3 clinical
trials, which pharma
submits to the FDA, are fundamentally tobacco trials carefully designed to make
the drug seem better than it is. The
only study that compared the raw data that had been submitted to the FDA found
that all 74 journal articles derived from these trials were biased; the average
positive bias 32%.[2] If the drug performs better
than nothing at all (a
placebo) for the condition treated a
very pharma
“friendly” FDA will grant a patent of exclusivity (which
typically with extensions lasts 16 years). Side effects are seldom used by the
FDA to deny a patent. Frequently the FDA
uses a surrogate outcome, for example the lowering of cholesterol level or
blood pressure rather than heart attacks.
For statins and antihypertensive drugs, the surrogate endpoint in the
short-term phase 3 does not inform doctors on the incidence of death, heart
attack, and all the side effects, or how real-world patients will fare[3]. Pharma uses a very select group of volunteers
in their clinical trial, ones that will respond better than the real-world
population. Pharma now outsources most
clinical trials to corporations which run them in under-developed
countries. This presents more wiggle
room for cooking the raw data to favor the drug. And it
gets worse. After approval by the
FDA, pharma runs low-quality, phase-4 trials not submitted to the FDA which to
an even greater extent hide side effects and exaggerate benefits, or serve
other marketing objectives such as on new uses for the drug, show off-patent
drugs are inferior, etc. The results of
clinical trials are written up by and for pharma in a way that adds even more
bias.[4] They are published in medical journals after
a rubber-stamped peer review. Reviewers
never see the raw data. The journal
articles by design misinform doctors as
to how their patients will do. Drugs
are taken based upon bias-journal articles that claim for the real-world
population they will significantly lengthen
and/or improve the quality of life. The method of reporting patient side effects has been
given to pharma, thus it is broken.
Physician on a voluntary basis can send a
report of a patient side effect to the drug manufacturer. That manufacturer
“evaluates” the thousands
of physician’s reports and sends their summation to the FDA, often years
later. Over-and-over again harm surfaces
years later; for example, Vioxx and Celebrex caused over 55,000 U.S. deaths
from heart attacks and strokes before it became public 5 years after Merck
& the FDA had strong evidence of the association of Vioxx with heart
attacks. The
doctors are aware that the broken information system harms patients, yet they
rely upon it; why?
Nine
compelling factors explain why doctors play ball with big pharma: 1) clinical
guidelines are written by KOLs to promote drugs; 2) hospital
administrators use those guidelines to set up treatment goals which their
physicians must meet as a condition of employment. 3) difficulty of researching
the journals for
the best treatments because of the mountains of tobacco science arising from a
fractured system of peer review and clinical trials; 4) those same KOLs write the chapters in medical textbooks; 5) KOLs
give continuing education classes (CEC);
6) through the combination of 1, 3, 4, & 5, pharma frames the discussion of
medical topics for their financial gains; 7) ad post hoc fallacy: what
was done works; 8) human factors including patient expectations, peer approval,
supervisor approval, and substantial financial rewards given by pharma who
tracks the prescriptions given by physicians; and 9) the negative consequences
for practicing medicine that is contrary to the clinical guidelines. The confluence
of these factors and human
tendency of doctors to bond with their profession (we are a social animal, like
soldiers in an army) entail that 95% of physicians won’t go into independent
practice like Dr. Stephen
Sinatra. Wearing
the boots of the physician opens the doors of perception, thus what follows is as seen through
the eyes of a main-street cardiologist.
Knowing the journals
are full of tobacco science doesn’t change the fact that I must work within the
existing structure in which treatments are dispensed. First, at the heart of medical practice are the
clinical guidelines. I know that select pro-pharma KOLs create guidelines for the American
Heart Association, the National Institute for Health (NIH) and others based mainly
upon the dodgy marketing phase-4
trials. I know that if sued for
malpractice for deviating from standard practice that in courts it is unlikely that
I could convince a jury and judge that guidelines
are rubbish! Second, these guidelines are used
by my hospital administrator to set up treatment standards. They are incorporated
into the patients’ computer
records. For example, if a patient’s blood pressure is high, the computer
screen will list recommended drugs. What
I prescribe is recorded in that record.
Moreover the hospital administrator as supervisor sets up goals which
the doctors must meet to continue employment at that hospital. I must meet those
standards to remain
affiliated with my hospital.[5] This condition of employment entails that my finding
what is in the best patients’ treatments will reduce my ability to sell the
patient on the mandated treatment, and eventual ending in termination of my
position. I have observed among most of
my colleagues a reluctance to question the junk guidelines and their junk
science. Third,
I do not go to a university medical library to access online the journals and
attempt to find, for example, what is in the best way to control hypertension
for additional reasons. Pharma funds,
direct, and also own the data of their clinical trials. Because clinical trials
are dressed as science,
I would have to read each journal article and look for gaps in analysis. Most
times all I find is that the body of the
article does not support two parts of the journal article: its conclusion and
abstract.[6] I know that the journal articles receive a sham-peer review: the reviewers read only what pharma includes
in manuscript; the raw data and other details necessary for a critical review
are not sent as axillary materials. The
published evidence is marketing spin dressed as science. The task at arriving
at spin free answer on
how best to treat hypertension would consume over 800 hours, and my conclusion
would be tentative given that most trials are not designed to provide answers,
just promote sales of a drug. Knowing this I am highly skeptical of what I read
in the journal articles—a source I seldom turn to. Fourth, given the broken evidence base, I turn
to the leading experts, pharma’s KOLs.
These doctors & professors obtain their status mainly by partaking
in clinical trials which pharma sets up, controls, and owns the data. The researchers
sign a contract that gives
pharma control over the data and publications.
The journal articles that the KOLs
publish with their names as authors are with few exceptions ghost-written by
companies hired by pharma. Pharma pays
these KOLs an honorarium for their
services. These same KOLs lecture
me in a pharma-funded and
ran CEC—continuing education classes
required by law. There I am told the best
treatment for hypertension is combination of 3 Pfizer drugs if the class is
funded by Pfizer. I hear a plausible
modus operandi (method of operation) on how these drugs
work. I learn that hypertension accelerates
the formation of plaque in arteries and the blood clots which cause heart
attacks and strokes. Of the over 120
drugs in 7 categories--based on their method of action--the best are those by Pfizer.
At the end of the class I am given 4 journal
reprints all of which are on Pfizer’s drugs. I follow the KOL’s recommendations
because it is considered sound medicine.
Moreover, my
colleagues believe in managing hypertension saves lives. Over and over again
I hear the KOLs mantra: “safe and effective”.
What they tell me--though spun--provides
material for discussion with patients and colleagues. Fifth, given the
marketing distortion favoring sponsor, for my main source I turn to medical
textbooks, Wikipedia, and The Merck Manual
for information on
drugs, treatments, and information on the causes and processes involved on
various conditions. I rely on these
sources though I know that they promote the uses of the newer drugs and distort
for that purpose the biology behind related to the condition. It is better than
CEC.
There is a seamless fit between guidelines, textbooks that tie into a
scenario. In this way pharma frames the
discussion of drugs, treatments, and causes. Sixth, we think in temporal-causal order: I
take Tylenol and 80% of the time within two
hours my headache is gone; therefore I believe Tylenol works. I give hypertensive
medications and 80% of my
patients don’t have a heart attack within 5 years. This is the ad post hoc ergo propter hoc fallacy
(post hoc fallacy) which
means “after this because of this”. Selective
memory enhances this fallacy. Thus I
have faith in some of the treatment guidelines, and the others I am uncertain
as to their merit. Seventh, there
are pleasing human factors. I like to
help my patients. Most are thankful that
I am trying to manage their hypertension, because they believe, like me, that
by lowering blood pressure their risk for an adverse event is significantly
reduced. Their family is thankful, and
my colleagues praise my efforts. The clinic’s
administrator is pleased that I follow the hospital’s guidelines. Being
part of the medical establishment is
being part of a revered organization; I am proud of the title “doctor”.
I receive over $20,000 in perks from Pfizer
for promoting their patented drugs based upon my prescribing record obtained
from IMS Health. These human
factors are another reason to
follow the guidelines for hypertension, though I am moderately skeptical about some
of them. Ninth,
I know a critic of the
broken system, but I don’t believe his claim that hypertension drugs do more harm than good. He ignores
the positive clinical published
trials, and he has cherry picked the negative evidence. Pharma and the media
fortunately have
marginalized the critics, thus limit the harm they cause. These critics, because
they don’t follow the
guidelines, don’t work at a large clinic or hospital. In private practice,
most have a small patient
base and thus limited income. Doctors such as Stephen Sinatra don’t receive
referrals from me or my colleagues. Most
patients want the latest, best drugs, not what Dr. Sinatra recommends: fish
oil, CoQ10, l-carnitine, d-ribose, etc. I believe that Dr. Sinatra has a religious
faith in naturalistic, alternative medicine--a faith contradicted by pharma’s clinical
trials. Thus because of the confluence
of all these reasons stated above, I won’t break rank with my colleagues. I
sincerely attempt to do the best for
my patients in our imperfect, corporate-governed world.
[1] Less
than 1 per year major government trials are ran, and without exception is done
with consultation with pharma and ran by their KOLs. The last to trouble
industry was the ALLHAT trial completed in 2002, which found a very cheap
diuretic better than patented drugs. Guidelines were adjusted to recommend
for
hypertension starting treatment with a diuretic. Results for all these drugs
in the prevention
of heart attacks was not statistically significant. There was no placebo group compare to
side effects or to show that there was a reduction in heart attacks and deaths,
which there isn’t, and is why pharma uses blood pressures instead.
[2] The New England Journal of
Medicine in 2008 published a study of 74 journal articles on 12
antidepressant agents involving 12,564 patients. “According to the published literature, it
appeared that 94% of the trials conducted were positive. By contrast, the FDA
analysis showed that 51% were positive.”
This
entails that our government through its FDA supports corporate profits more
than public health: the FDA is part of
the problem and not the fix. The journal
articles on all of the trials have all been spun to make the drugs worth their
side effects. See recommended
gateway for the index
of article exposing bad pharma, and healthful alternatives.
[3]
Pharma selects patients that will respond better than the norm to the
drug. Then usually they run a wash
out period in a phase iii
trial: the volunteers are given the
drugs for a month or more, then those whose results are unfavorable are culled
from the group. Then the trial is
started with the remaining volunteers.
This wash out period is not referenced in the journal articles.
[4] An
industry has developed of companies which ghost-write the articles, then submit
the article to the putative lead person on the trial, research, or review of
treatment choices for a signature by the KOL.
By this methods a trial is submitted on an average to over 6 different
journals to published the spun favorable outcomes.
[5]
Pharma through an assortment of ways pumps billions of dollars into the coffers
of corporate hospitals for them to set up guidelines incorporated into the hospital-patient
record system, and pharma buys from data-mining companies the performance of
the hospitals and their doctors. For a
fee, pharmacies sell their prescription records. Maine and New Hampshire barred
this practice,
but had their laws declared unconstitutional by the Supreme Court in June 2011.
[6]
Over 90% of the time doctors read just the abstract and/or conclusion section
of the article. The detailed, long body
of the article is spun to favor pharma
in those two summary sections; it is a standard practice often done by a pharma
ghost writer.
|